Results 11 to 20 of about 25,533 (219)
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler [PDF]
Editor—The study by Ayres et al may have been selectively designed to promote a product as safe; they endorse it as conforming to unpublished guidelines for postmarketing surveillance studies under safety assessment of marketed medicines.1 Withdrawals from the study are mainly for reasons “not related to safety,” and the withdrawal rate of the product ...
M G Bamber+6 more
openaire +4 more sources
Regulatory approvals for the marketing of medicinal products authorize medical practitioners to prescribe drugs to a group of patients that are defined within the license of the medicinal product.
Nikhil Raj+5 more
doaj +2 more sources
ABSTRACT Clinical trials have demonstrated the efficacy and safety of guselkumab in patients with moderate‐to‐severe plaque psoriasis. Real‐world evidence for guselkumab in Korea is needed to establish drug safety and effectiveness under real‐world practice in this population.
Bong Seok Shin+13 more
wiley +2 more sources
Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH [PDF]
Clinical ...
F. Peyvandi+6 more
semanticscholar +5 more sources
Characteristics of safety information obtained from postmarketing observational studies for re-examination in Japan [PDF]
BackgroundIn Japan, postmarketing surveillance (PMS) studies are required for newly approved drug products to further collect safety information in clinical settings.
Tatsuya Watanabe, M. Narukawa
semanticscholar +3 more sources
Importance The US Food and Drug Administration (FDA) is building a national postmarketing surveillance system for medical devices, moving to a "total product life cycle" approach whereby more limited premarketing data are balanced with postmarketing ...
Wang X+6 more
europepmc +2 more sources
Gilteritinib has been approved as monotherapy in adults with acute myeloid leukemia (AML) FLT3 mutated with relapsed or refractory disease, in light of its advantages in terms of survival and the favorable safety profile.
L. Gozzo+16 more
semanticscholar +1 more source
Several formulations of the aromatase inhibitor anastrozole are available in Brazil. We carried out a postmarketing surveillance of the anastrozole (test) formulation in current use at the Brazilian National Cancer Institute (INCA), by comparing ...
Manuela Vasquez Cardoso+7 more
semanticscholar +1 more source
Real-World Use of Generic Meropenem: Results of an Observational Study
Background: To determine the therapeutic effect and tolerability of meropenem in routine clinical practice, in terms of clinical and microbiological response.
Santiago Garnica-Velandia+2 more
doaj +1 more source
Introduction In the absence of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring potential adverse reactions to secure a high ...
M. Banach+7 more
semanticscholar +1 more source